In Brief: Alamar Biosciences
This article was originally published in The Gray Sheet
Executive Summary
Alamar Biosciences: In vitro diagnostics manufacturer signs letter of intent to merge in a stock-swap agreement with Accumed, a privately-held laboratory diagnostics products manufacturer. The exchange of stock would give Alamar shareholders 51% ownership of the combined company, to be called Accumed...